App-Quantinova.ai

HEART VALVULAR INVOLVEMENT IN THE ANTIPHOSPHOLIPID SYNDROME. AN ECHOCARDIOGRAPHIC DESCRIPTIVE STUDY

I. Pons - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

DISTURBANCES OF T AND B CELL HOMEOSTASIS CHARACTERIZED PRIMARY ANTIPHOSPHOLIPID PATIENTS DURING THEIR FOLLOW-UP OF VENOUS THROMBOEMBOLISM

L. Simonin - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PREDNISONE INCREASES BOTH ARTERIAL AND VENOUS THROMBOSIS IN SLE

K. Hickman - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Prednisone

A MULTICENTER PROSPECTIVE EVALUATION OF THE RISK PROFILE IN PREGNANT PATIENTS WITH PERSISTENT POSITIVITY FOR ANTIPHOSPHOLIPID ANTIBODIES (APL)

M. Fredi - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

MICROPARTICLES IN 290 SLE PATIENTS AND MATCHED CONTROLS AND THEIR RELATIONSHIP TO VASCULAR DISEASE

A. Vikerfors - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylserine

ANTI-ANNEXIN II: A NOVEL MARKER IN ANTIPHOSPHOLIPID SYNDROME

E. Soliman - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH CEREBROVASCULAR EVENTS

N - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylserine

IGA ANTI-PHOSPHATIDYLSERIN/PROTHROMBIN ANTIBODIES PRESENT A THROMBOTIC RISK IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

P. Zigon - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS & INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY (REGISTRY) CLUSTER ANALYSIS FOR IDENTIFICATION OF DIFFERENT CLINICAL PHENOTYPES AMONG ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS

S. Zuily - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

TOP-5

HISTOPATHOLOGY OF ANTIPHOSPHOLIPID NEPHROPATHY IN SAUDIS

A. Alarfaj - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

CARDIAC INVOLVEMENT IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A CASE SERIES WITH A LONG-TERM FOLLOW-UP

A.I. Martinez-Vidal - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ASSOCIATION OF THE METABOLIC SYNDROME (METS) WITH VASCULAR COMPLICATIONS, END STAGE RENAL FAILURE (ESRF) AND MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A COHORT ANALYSIS

C.C. Mok - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

ANTIPHOSPHOLIPID ANTIBODIES PROFILE AND THROMBOSIS RECURRENCE

G. Medina - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

AGE IS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTIPHOSPHOLIPID ANTIBODY CARRIERS

I. Les - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

CLINICAL FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID SYNDROME IN CHILDREN

P.K. Ishuova - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

DILUTE RUSSEL VENOM TIME RATION INDEPENDENTLY PREDICTS MORTALITY IN PRIMARY ANTIPHOSPHOLIPID SYNDROME

P. RJ Ames - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

ISOTYPES OF ANTI-BETA 2- GLYCOPROTEIN I IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: CORRELATION WITH CLINICAL MANIFESTATIONS, LABORATORY FEATURES AND ASSOCIATION WITH ANTIPHOSPHOLIPID SYNDROME

D. Attia - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

REGULATION OF ATHEROTHROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. ROLE OF DIFFERENT MONOCYTE SUBSETS, NETOSIS INVOLVEMENT, AND EFFECTS OF ANTI-DSDNA ANTIBODIES

C. Perez-Sanchez - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

glutathione

REMOVAL OF PATHOGENIC ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID SYNDROME

I.P. Gontar - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

INCREASED SERUM TIE-2 LEVEL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND RELATED FACTORS

O.N. Pamuk - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

L-Tyrosine

Filters

7277 Abstracts